Goal

Optogenerapy aims to develop and demonstrate a new optogenetics implant for controlled beta interferon (IFN- ß) protein delivery for treating patients suffering from multiple sclerosis

Are you a clinician?

We are looking for clinicians working on Multiple Sclerosis willing to participate in the project by providing their feedback on Optogenerapy’s medical device by answering a short survey via email or telephone call. Your feedback will be considered by project partners and integrated, when possible, during the project development.

 

Interested clinicians will be also invited to Optogenerapy’s clinical training workshops, aiming at presenting the implant to the medical professional community and enriching the clinical know-how.

Contact us

I am interested in providing feedback to Optogenerapy project (*required)

Impact

For Patients

Improve drug effectiveness
Improve compliance with drug taking

For System

Reduce direct and indirect costs
linked to Multiple Sclerosis

For Society

Social awareness of efficient therapies
improving patient compliance

Partners

eth_zurich
politechnika
erasmus
genexplan
ase-optics
neos_surgery
ultrasion
inserm
une
Do NOT follow this link or you will be banned from the site!